Asia Pacific Molecular Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)

No. of Pages: 167    |    Report Code: TIPRE00026008    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Molecular Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Molecular Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Molecular Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Development of new products and increase in demand for point-or-care testing
5.2 Market Opportunities
  • 5.2.1 Advancement in Molecular Diagnostics Technologies
5.3 Future Trends
  • 5.3.1 Molecular Diagnostics in Personalized Medicine
5.4 Impact of Drivers and Restraints

6. Asia Pacific Molecular Diagnostics Market Regional Analysis

6.1 Asia Pacific Molecular Diagnostics Market Overview
6.2 Asia Pacific Molecular Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Molecular Diagnostics Market Forecast Analysis

7. Asia Pacific Molecular Diagnostics Market Analysis – by Disease Area

7.1 Oncology
  • 7.1.1 Overview
  • 7.1.2 Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Infectious Disease
  • 7.2.1 Overview
  • 7.2.2 Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Genetic Testing
  • 7.3.1 Overview
  • 7.3.2 Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Cardiac Diseases
  • 7.4.1 Overview
  • 7.4.2 Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Immune System Disorders
  • 7.5.1 Overview
  • 7.5.2 Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Molecular Diagnostics Market Analysis – by Technology

8.1 Polymerase Chain Reaction
  • 8.1.1 Overview
  • 8.1.2 Polymerase Chain Reaction: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Isothermal Nucleic Acid Amplification Technology
  • 8.2.1 Overview
  • 8.2.2 Isothermal Nucleic Acid Amplification Technology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 DNA Sequencing & Next-Generation Sequencing
  • 8.3.1 Overview
  • 8.3.2 DNA Sequencing & Next-Generation Sequencing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 DNA Microarrays
  • 8.4.1 Overview
  • 8.4.2 DNA Microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 In-Situ Hybridization
  • 8.5.1 Overview
  • 8.5.2 In-Situ Hybridization: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Molecular Diagnostics Market Analysis – by Product and Services

9.1 Assays & Kits
  • 9.1.1 Overview
  • 9.1.2 In-Situ Hybridization: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Instruments
  • 9.2.1 Overview
  • 9.2.2 In-Situ Hybridization: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Services & Software
  • 9.3.1 Overview
  • 9.3.2 In-Situ Hybridization: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Molecular Diagnostics Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Molecular Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 Asia Pacific Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Molecular Diagnostics Market Breakdown, by Disease Area
    • 10.1.1.1.2 China: Asia Pacific Molecular Diagnostics Market Breakdown, by Technology
    • 10.1.1.1.3 China: Asia Pacific Molecular Diagnostics Market Breakdown, by Product and Services
  • 10.1.1.2 India: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Molecular Diagnostics Market Breakdown, by Disease Area
    • 10.1.1.2.2 India: Asia Pacific Molecular Diagnostics Market Breakdown, by Technology
    • 10.1.1.2.3 India: Asia Pacific Molecular Diagnostics Market Breakdown, by Product and Services
  • 10.1.1.3 Japan: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Molecular Diagnostics Market Breakdown, by Disease Area
    • 10.1.1.3.2 Japan: Asia Pacific Molecular Diagnostics Market Breakdown, by Technology
    • 10.1.1.3.3 Japan: Asia Pacific Molecular Diagnostics Market Breakdown, by Product and Services
  • 10.1.1.4 Australia: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Molecular Diagnostics Market Breakdown, by Disease Area
    • 10.1.1.4.2 Australia: Asia Pacific Molecular Diagnostics Market Breakdown, by Technology
    • 10.1.1.4.3 Australia: Asia Pacific Molecular Diagnostics Market Breakdown, by Product and Services
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Molecular Diagnostics Market Breakdown, by Disease Area
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Molecular Diagnostics Market Breakdown, by Technology
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Molecular Diagnostics Market Breakdown, by Product and Services

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Molecular Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Agilent Technologies Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 bioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Danaher
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Illumina Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Novartis AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Qiagen NV
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Siemens Healthineers AG
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 TBG Diagnostics Limited
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Thermo Fisher Scientific Inc
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

  1. Abbott Laboratories
  2. Agilent Technologies Inc
  3. bioMerieux SA
  4. Danaher
  5. F. Hoffmann-La Roche Ltd
  6. Illumina Inc
  7. Novartis AG
  8. Qiagen NV
  9. Siemens Healthineers AG
  10. TBG Diagnostics Limited
  11. Thermo Fisher Scientific Inc
asia-pacific-molecular-diagnostics-market